Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7311 p176
7 August 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Electronic Signatures Regulations 2002 (more)
Consultation document (PDF 70K)
Online comment form (more)


Electronic prescription signatures plan

Consultation has started on a proposal to change the law throughout the UK to allow prescriptions to be signed electronically. The law needs to change because prescriptions can only currently be signed in ink and this precludes electronic prescription transmission.

The plan is to amend the Prescription Only Medicines (Human Use) Order 1997 so that electronic prescriptions can be signed with advanced electronic signatures (AES), ie, ones that are uniquely linked to the signatories.

An AES is also capable of identifying the signatory, is created using means that can be maintained under the signatory’s sole control and is linked to the data to which it relates in such a manner that any subsequent change of the data is detectable.

Comments on the proposed law change can be sent to Roy Drepaul, Medicines and Healthcare products Regulatory Agency, Market Towers, 1 Nine Elms Lane, London SW8 5NQ (e-mail roy.drepaul@mhra.gsi.gov.uk) until 29 October.

Before NHS prescriptions can be transmitted electronically, amendments will also need to be made to relevant NHS legislation for England, Scotland, Wales and Northern Ireland.

The advanced electronic signature proposal does not apply to prescriptions for Schedule 1, 2 or 3 Controlled Drugs. In March 2003, the Home Office consulted on proposals to allow all details except signatures to be generated by computer on prescriptions for Schedule 2 and 3 CDs. Amendments to the Misuse of Drugs Regulations 2001 are awaited.

Back to Top


©The Pharmaceutical Journal